Tucatinib, Trastuzumab, and Capecitabine for the Treatment of HER2+ LMD
Clinical trial NCT03501979 · TERMINATED
Trial details
- NCT number
- NCT03501979
- Sponsor
- University of Alabama at Birmingham
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-20
- Primary completion
- 2021-06-22
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.